DALLAS--()--Baron & Budd, P.C. attorney John Langdoc commended the release of a new report on lung cancer in women titled “Out of the Shadows: Women and Lung Cancer.” The report was released by the Mary Horrigan Connors Center at Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, on April 26 and aims to bring attention to lung cancer, particularly never-smoker lung cancer.
“Out of the Shadows: Women and Lung Cancer.”
“It’s great to see groups taking the initiative on never-smoker lung cancer, particularly in women,” said Langdoc. “So many people associate lung cancer with smoking, and just aren’t aware that lung cancer can be caused by things other than smoking and, unfortunately, that lung cancer kills more women each year than any other cancer.”
According to the report, one in five women who develop the disease are never-smokers and, in 1987, lung cancer surpassed breast cancer as the leading cause of cancer death in the U.S. While many advancements in the field of lung cancer have occurred in recent years, there are still considerable gaps in research and funding to help understand this deadly cancer.
“More research needs to be done to unravel the mysteries behind never-smoker lung cancer in women,” said Langdoc. “This report is hopefully the beginning of a stronger initiative to strengthen national awareness and research for lung cancer.”
Over the past year, Baron & Budd has worked with lung disease awareness advocate Deborah Morosini, M.D. to help raise awareness of never-smoker lung cancer and to highlight the environmental toxins that have contributed to the rise in this cancer.
About Baron & Budd, P.C.
Dallas-based Baron & Budd, P.C., with offices in Baton Rouge, Austin and Beverly Hills, is a nationally recognized firm with more than three decades of experience representing people and communities harmed by corporate negligence. The firm resolved one of the first asbestos cases in the United States in the 1970s and continues to serve people diagnosed with mesothelioma and asbestos-related lung cancer as well as communities and consumers dealing with the costs of fraud and corporate misconduct.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6266423&lang=en

